Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039248659> ?p ?o ?g. }
- W3039248659 endingPage "6660" @default.
- W3039248659 startingPage "6651" @default.
- W3039248659 abstract "Breast cancer is one of the most common and malignant tumors in the world. Nowadays more attention has been garnered in pristimerin anti-cancer effects. Here, we illustrate the function and regulatory mechanism of pristimerin in breast cancer therapy.Breast cancer cell lines MCF-7, MDA-MB-231, and 4T1 were used. Cell Counting Kit-8 (CCK-8) assay was performed to evaluate proliferation viability of breast cancer cells under pristimerin treatment. Wound healing assay was used to examine the migration ability, cell cycle, and cell apoptosis detection were tested by flow cytometry. Bioinformatic analysis was used to find the underlying molecular and gene connected with pristimerin and breast cancer survival. Finally, we used transfection and real-time polymerase chain reaction analysis to confirm the mechanism.We observed that pristimerin inhibited breast cancer cell viability, migration, and cell cycle, meanwhile induced cell apoptosis. In addition, under pristimerin treatment, miR-542-5p was up-regulated while DUB3 was down-regulated. Furthermore, bioinformatics analysis showed higher expression of DUB3 in breast cancer compared with normal tissue, also with poor prognosis. Overexpression miR-542-5p in breast cancer cells leads to a decrease in DUB3 level. The effect was obviously post pristimerin treatment and miR-542-5p overexpression.Pristimerin inhibited breast cancer progression through DUB3 expression via a canonical miRNA-mediated mechanism." @default.
- W3039248659 created "2020-07-10" @default.
- W3039248659 creator A5039225458 @default.
- W3039248659 creator A5052625399 @default.
- W3039248659 creator A5063900505 @default.
- W3039248659 creator A5078887137 @default.
- W3039248659 creator A5084002636 @default.
- W3039248659 creator A5084378338 @default.
- W3039248659 date "2020-07-01" @default.
- W3039248659 modified "2023-10-16" @default.
- W3039248659 title "<p>Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis</p>" @default.
- W3039248659 cites W1853758218 @default.
- W3039248659 cites W1974254202 @default.
- W3039248659 cites W2007505836 @default.
- W3039248659 cites W2010778165 @default.
- W3039248659 cites W2014065745 @default.
- W3039248659 cites W2035101957 @default.
- W3039248659 cites W2041602672 @default.
- W3039248659 cites W2054067310 @default.
- W3039248659 cites W2055193388 @default.
- W3039248659 cites W2077212116 @default.
- W3039248659 cites W2080232352 @default.
- W3039248659 cites W2081734005 @default.
- W3039248659 cites W2117515893 @default.
- W3039248659 cites W2123188794 @default.
- W3039248659 cites W2139364069 @default.
- W3039248659 cites W2142450574 @default.
- W3039248659 cites W2143151366 @default.
- W3039248659 cites W2154526900 @default.
- W3039248659 cites W2155318279 @default.
- W3039248659 cites W2162674813 @default.
- W3039248659 cites W2201010538 @default.
- W3039248659 cites W2297893913 @default.
- W3039248659 cites W2298441163 @default.
- W3039248659 cites W2435485445 @default.
- W3039248659 cites W2507880739 @default.
- W3039248659 cites W2526503051 @default.
- W3039248659 cites W2570537891 @default.
- W3039248659 cites W2588238973 @default.
- W3039248659 cites W2757175627 @default.
- W3039248659 cites W2781525129 @default.
- W3039248659 cites W2790169551 @default.
- W3039248659 cites W2889646458 @default.
- W3039248659 cites W2906776957 @default.
- W3039248659 cites W2911683257 @default.
- W3039248659 cites W2912404095 @default.
- W3039248659 cites W2913469816 @default.
- W3039248659 cites W2918541749 @default.
- W3039248659 cites W2934750731 @default.
- W3039248659 cites W2948648662 @default.
- W3039248659 doi "https://doi.org/10.2147/ott.s257329" @default.
- W3039248659 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7354954" @default.
- W3039248659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32753899" @default.
- W3039248659 hasPublicationYear "2020" @default.
- W3039248659 type Work @default.
- W3039248659 sameAs 3039248659 @default.
- W3039248659 citedByCount "13" @default.
- W3039248659 countsByYear W30392486592020 @default.
- W3039248659 countsByYear W30392486592021 @default.
- W3039248659 countsByYear W30392486592022 @default.
- W3039248659 countsByYear W30392486592023 @default.
- W3039248659 crossrefType "journal-article" @default.
- W3039248659 hasAuthorship W3039248659A5039225458 @default.
- W3039248659 hasAuthorship W3039248659A5052625399 @default.
- W3039248659 hasAuthorship W3039248659A5063900505 @default.
- W3039248659 hasAuthorship W3039248659A5078887137 @default.
- W3039248659 hasAuthorship W3039248659A5084002636 @default.
- W3039248659 hasAuthorship W3039248659A5084378338 @default.
- W3039248659 hasBestOaLocation W30392486591 @default.
- W3039248659 hasConcept C104317684 @default.
- W3039248659 hasConcept C109541995 @default.
- W3039248659 hasConcept C121608353 @default.
- W3039248659 hasConcept C126322002 @default.
- W3039248659 hasConcept C145059251 @default.
- W3039248659 hasConcept C1491633281 @default.
- W3039248659 hasConcept C185592680 @default.
- W3039248659 hasConcept C190283241 @default.
- W3039248659 hasConcept C203014093 @default.
- W3039248659 hasConcept C29537977 @default.
- W3039248659 hasConcept C2994423619 @default.
- W3039248659 hasConcept C502942594 @default.
- W3039248659 hasConcept C530470458 @default.
- W3039248659 hasConcept C53227056 @default.
- W3039248659 hasConcept C54009773 @default.
- W3039248659 hasConcept C553184892 @default.
- W3039248659 hasConcept C55493867 @default.
- W3039248659 hasConcept C71924100 @default.
- W3039248659 hasConceptScore W3039248659C104317684 @default.
- W3039248659 hasConceptScore W3039248659C109541995 @default.
- W3039248659 hasConceptScore W3039248659C121608353 @default.
- W3039248659 hasConceptScore W3039248659C126322002 @default.
- W3039248659 hasConceptScore W3039248659C145059251 @default.
- W3039248659 hasConceptScore W3039248659C1491633281 @default.
- W3039248659 hasConceptScore W3039248659C185592680 @default.
- W3039248659 hasConceptScore W3039248659C190283241 @default.
- W3039248659 hasConceptScore W3039248659C203014093 @default.
- W3039248659 hasConceptScore W3039248659C29537977 @default.
- W3039248659 hasConceptScore W3039248659C2994423619 @default.